Drugplain

Qsymia 7.5 mg/1

phentermine and topiramate · CAPSULE, EXTENDED RELEASE · Vivus LLC

No Recall History
Plain English

Qsymia is a prescription medication containing phentermine and topiramate that is used to help with weight loss in people who are obese or overweight with weight-related health conditions. It works through multiple mechanisms, including appetite suppression and metabolic effects.

Key Facts

Brand Name
Qsymia
Generic Name
phentermine and topiramate
NDC Code (Product)
62541-202
Manufacturer
Vivus LLC
Strength
7.5 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule IV (Controlled)
Application #
NDA022580
Drug Class
Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]
Marketing Start
09/17/2012

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

headache362 reports
paraesthesia323 reports
insomnia277 reports
dry mouth273 reports
dizziness262 reports
weight increased262 reports
feeling abnormal218 reports
fatigue213 reports
nausea206 reports
constipation200 reports

Frequently Asked Questions

What is Qsymia used for?

Qsymia is a prescription medication containing phentermine and topiramate that is used to help with weight loss in people who are obese or overweight with weight-related health conditions. It works through multiple mechanisms, including appetite suppression and metabolic effects.

Is Qsymia a controlled substance?

Yes, Qsymia is classified as CIV under the DEA Controlled Substances Act.

What is the generic name for Qsymia?

The generic name for Qsymia is phentermine and topiramate. There are 10 other brand versions of phentermine and topiramate.

What is the NDC code for Qsymia 7.5 mg/1?

The NDC (National Drug Code) for Qsymia 7.5 mg/1 is 62541-202, listed by Vivus LLC.